Latest News Archive

Please select Category, Year, and then Month to display items

#YouthMonth: UFS makes strides in youth career development

30 June 2023 | Story Valentino Ndaba | Photo Supplied

CareerHub: connecting UFS students to dream jobs

In response to the alarming rate of unemployment facing South Africa's young population, the government has launched various youth development and empowerment projects as part of the Presidential Youth Employment Intervention, aiming to encourage greater youth participation in the economy.

To combat the high rate of graduate unemployment, the University of the Free State (UFS) Career Services in the Division of Student Affairs plans to launch the CareerHub on 3 July 2023. CareerHub is an innovative job portal aimed at revolutionising the job search process and connecting employers with highly qualified UFS candidates. The platform boasts a wide range of opportunities, collaborates with reputable companies, offers advanced search filters, and enables employers to create detailed company profiles to attract top talent. Job seekers can personalise their search criteria and set preferences to streamline their job search.

UFS Youth Month campaign

Highlighting the positive impact of the UFS in youth career development, the institution's Department of Communication and Marketing launched a campaign in June 2023 aimed at showcasing the success stories of alumni who have studied at the university and are now employed by the institution.

One such success story is Katleho Lechoo, who joined the UFS as an undergraduate student and is now a football administrator in KovsieSport. Lechoo's journey exemplifies his commitment to excellence, having served as the President of the Institutional Student Representative Council during his time as a student. Reflecting on his experiences, Lechoo expressed gratitude for the opportunities to contribute positively and to make a difference in the UFS community.

“I was recently elected as the youngest Institutional Forum member at the University of the Free State. A position I look at and remind myself that – apart from my ordinary position at the university – I also have an opportunity to contribute and influence the space positively and otherwise for its benefit. I wake up knowing that I have yet another day to do good unto others as I would expect from them. And to sum up my experience thus far? As Roy T Bennett simply puts it: ‘Be thankful for everything that happens in your life; it’s all an experience’,” said Lechoo.

Annelize Kruger shared Lechoo’s sentiments. Kruger graduated in 2020 with a Master of Science in Occupational Therapy and now serves as a lecturer in the Department of Occupational Therapy. She credits the UFS for providing her with a solid foundation to excel in her profession and to contribute to the training of future occupational therapists.

Maximising impact through the SDG lens

The introduction of CareerHub aligns with the UFS' Vision 130 strategy, which aims to maximise societal impact and contribute to the development of the Free State and South Africa. The platform addresses a pressing local issue – youth unemployment – by leveraging the United Nations’ Sustainable Development Goals (SDGs) as a framework for assessing societal impact.

SDG Goal eight, focusing on Decent Work and Economic Growth, highlights the importance of providing young people with opportunities for decent jobs. This involves investing in quality education and training, matching skills with market demands, ensuring social protection and basic services, and promoting equal opportunities for productive employment, irrespective of gender, income level, or socio-economic background.

WATCH: UFS ends Youth Month on a high note with a performance from the 1992 film Sarafina!

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept